Invention Grant
- Patent Title: Antibodies directed to HER-3 and uses thereof
-
Application No.: US16155859Application Date: 2018-10-09
-
Publication No.: US11267900B2Publication Date: 2022-03-08
- Inventor: Mike Rothe , Martin Treder , Eric Borges , Larry L. Green , Susanne Hartmann
- Applicant: DAIICHI SANKYO EUROPE GMBH , AMGEN INC
- Applicant Address: DE Munich; US CA Thousand Oaks
- Assignee: DAIICHI SANKYO EUROPE GMBH,AMGEN INC
- Current Assignee: DAIICHI SANKYO EUROPE GMBH,AMGEN INC
- Current Assignee Address: DE Munich; US CA Thousand Oaks
- Agency: Chao Hadidi Stark & Barker LLP
- Agent Birgit Millauer
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K16/32 ; G01N33/574 ; C12N15/00 ; C12N15/63 ; C12N15/09 ; A61K39/00
Abstract:
The present invention relates to binding proteins that bind to HER-3 and polynucleotides encoding the same. Expression vectors and host cells comprising the same for the production of the binding protein of the invention are also provided. In addition, the invention provides compositions and methods for diagnosing and treating diseases associated with HER-3 mediated signal transduction and/or its ligand heregulin.
Public/Granted literature
- US20190263930A1 ANTIBODIES DIRECTED TO HER-3 AND USES THEREOF Public/Granted day:2019-08-29
Information query
